Cargando…
Bromodomains as therapeutic targets
Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biology. Enzymes that ‘write’ (histone acetyltransferases, HATs) and ‘erase’ (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug d...
Autores principales: | Muller, Susanne, Filippakopoulos, Panagis, Knapp, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177561/ https://www.ncbi.nlm.nih.gov/pubmed/21933453 http://dx.doi.org/10.1017/S1462399411001992 |
Ejemplares similares
-
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012) -
SH2 domains: modulators of nonreceptor tyrosine kinase activity
por: Filippakopoulos, Panagis, et al.
Publicado: (2009) -
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012) -
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014) -
Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding
por: Kempen, Herman J, et al.
Publicado: (2013)